Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass
Richard Gill, Taiyi Kuo
Richard Gill, Taiyi Kuo
View: Text | PDF
Research Article Endocrinology Metabolism

Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass

  • Text
  • PDF
Abstract

Obesity and type 2 diabetes (T2D) are metabolic diseases with increasing prevalence worldwide. Obesity often leads to T2D. Insulin resistance and impaired β cell function contribute to the onset of hyperglycemia. Previously, we reported that ablation of Gc, encoding a secreted protein with a primary role in vitamin D transport, improved pancreatic β cell function in models of diet-induced insulin resistance. Here, we show that Gc ablation had systemic insulin-sensitizing effects to prevent weight gain, hyperglycemia, and glucose intolerance; lower nonesterified fatty acids and triglycerides; and augment glucose uptake in skeletal muscle and adipose in male mice fed a high-fat diet. Interestingly, weight loss in Gc-ablated mice resulted from selective fat mass loss with preserved lean mass. Moreover, acute Gc inhibition prevented glucose intolerance caused by high-fat feeding. The data suggest that Gc inhibition can increase insulin production in β cells and insulin action in peripheral tissues, while reducing fat mass.

Authors

Richard Gill, Taiyi Kuo

×

Figure 1

Metabolic features of HFD-fed GcKO male mice.

Options: View larger image (or click on image) Download as PowerPoint
Metabolic features of HFD-fed GcKO male mice.
(A–C) Body weight (WT n = ...
(A–C) Body weight (WT n = 23, GcKO n = 30), fat mass (WT n = 23, GcKO n = 30), and lean mass (WT n = 23, GcKO n = 30) of HFD-fed WT and GcKO mice. (D) Fasting glycemia (WT n = 29, GcKO n = 53) of HFD-fed WT and GcKO mice. (E and F) I.p. glucose tolerance tests (ipGTT) performed and AUC calculated in HFD-fed WT (n = 14) and GcKO (n 25) mice. (G) Pyruvate tolerance test (PTT) performed and (H) AUC calculated in HFD-fed WT (n = 10) and GcKO (n = 23) mice. (I) Insulin tolerance test (ITT) performed and (J) AUC calculated in HFD-fed WT (WT = 8) and GcKO (n = 16) mice. “NS” indicates no significant statistical difference. Data are shown as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.005 by Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts